Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-3
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

Ancillary study of the PregMouv study which aims to evaluate an intervention allowing the best adherence of women in terms of physical activity. Several types of interventions are therefore planned in this study: no intervention, physical activity sessions in person, by videoconference or mixed (in person and videoconference) with accelerometer assessment of the level of physical activity practiced (in the form of energy expenditure, in MET). Thus, for our ancillary study, a comparison of the cardiac variability of newborns will be carried out according to the level of physical activity practiced by the mother regardless of the intervention she benefited from within the framework of the PregMouv study. A comparison of the average saturation and the time spent below 90% saturation will be carried out via a continuous recording of saturation by oximetry. A longitudinal follow-up for the assessment of height and weight growth (from growth curves) and neurodevelopment (by clinical examination and self-questionnaire) is also planned until the child is 2 years old.

Eligibility criteria

Qualifiers

All newborns of mothers who participated in the PregMouv study and who have at least one piece of data for the main criterion from the PregMouv study (physical activity at T1/T2),

born at the Clermont Ferrand University Hospital and after parental agreement for their child to participate may be included.

Disqualifiers

Newborns requiring aminergic support in the first days of life,

making heart rate variability analysis impossible,

having received invasive ventilatory support that does not allow analysis of the oximetry recording.

Parental refusal or inability of parents to give their consent for their child to participate.

Trial design

Treatments tested in this trial

  • Heart rate variability
  • Pulmonary function

Treatment groups

100 Participants
are divided into 1 treatment group